Prostate Cancer Prevention Drug Rejected

Links shared publicly online about this topic

FDA Panel Rejects Two Drugs for Prostate Cancer Prevention - AOL Health

aolhealth.com — “A panel of federal health on Wednesday rejected the use of two drugs from Merck and GlaxoSmithKline to prevent prostate cancer, saying the drugs couldView full resource at aolhealth.com

  • View Related
  • Share

Most Recently Shared on December 3, 2010 at 6:45 pm By:

HealthPop HealthPop Health Site

FDA rejects two drugs for prostate cancer prevention. http://aol.it/gxm8Zg #prostate #cancer

1 year ago...

FDA Panel Rejects Use of BPH Drugs for Prostate Cancer Prevention - Renal and Urology News

renalandurologynews.com — “An FDA advisory panel has voted against expanding the labeling of dutasteride (Avodart, GlaxoSmithKline) and finasteride (Proscar, Merck) so that these drugs--"which are indicated for the treatment of benign prostatic hyperplasia (BPH)--"could be marketed for the prevention of prostate cancer (PCa) in men at risk for the disease.View full resource at renalandurologynews.com

  • View Related
  • Share

Most Recently Shared on December 3, 2010 at 1:31 pm By:

renalandurology Renal Urology News Urology, Medical Publisher, Health News, and Nephrology

FDA Panel Rejects Use of BPH Drugs for Prostate Cancer Prevention: An FDA advisory panel has voted against expan... http://bit.ly/dNQ4zo

1 year ago...

Medical News: FDA Panel Rejects Prostate Drugs for CA Prevention - in Oncology/Hematology, Prostate Cancer from MedPage Today

medpagetoday.com — “SILVER SPRING, Md. -- An FDA advisory panel has voted overwhelmingly that GlaxoSmithKline's dutasteride (Avodart) and Merck's finasteride (Proscar) should not be used to prevent prostate cancer becausView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on December 2, 2010 at 12:37 am By:

MedicalNews Medical News Health News

FDA Panel Rejects Prostate Drugs for CA Prevention http://bit.ly/fgyEA8

1 year ago...

Prostate cancer drug rejected by NHS | totalhealth

totalhealth.co.uk — “A health watchdog has rejected calls by cancer charities to make the advanced prostate cancer drug, abiraterone, available on the NHS. The drug, which costs £3000 a month, is able to prolong the life of sufferers for over three months.View full resource at totalhealth.co.uk

  • View Related
  • Share

Most Recently Shared on February 10, 2012 at 10:19 am By:

totalhealth1 totalhealth

Prostate cancer drug rejected by NHS | totalhealth: http://t.co/X4C9gm54 via @AddThis #hcsm

4 months ago...

ODAC rejects expanded use for bone drug in men with prostate cancer | HemOncToday

hemonctoday.com — “The FDA’s Oncologic Drugs Advisory Committee rejected a request from Amgen to allow denosumab to be used as a preventive measure for men wView full resource at hemonctoday.com

  • View Related
  • Share

Most Recently Shared on February 9, 2012 at 1:11 pm By:

HemOncToday HemOnc Today Oncology and Health News

ODAC rejects expanded use for bone drug in men with prostate cancer: http://t.co/eFDclp28

4 months ago...

NHS rationing body rejects prostate cancer drug - Telegraph

healthcare.tweetmeme.com — “All the news on healthcareView full resource at healthcare.tweetmeme.com

  • View Related
  • Share

Most Recently Shared on September 30, 2011 at 9:06 am By:

TM_Healthcare Healthcare TweetMeme Health Social Media

NHS rationing body rejects prostate cancer drug - Telegraph http://t.co/IJ5DZ3tl (via @naturalimmune)

8 months ago...

ODAC rejects approval of dutasteride for prostate cancer prevention « THE "NEW" PROSTATE CANCER INFOLINK

prostatecancerinfolink.net — “ODAC rejects approval of dutasteride for prostate cancer prevention « THE "NEW" PROSTATE CANCER INFOLINKView full resource at prostatecancerinfolink.net

  • View Related
  • Share

Most Recently Shared on December 2, 2010 at 1:57 am By:

prostatediaries john clay mchugh Surgeon, Urologist, Physician, and Doctor

ODAC rejects approval of dutasteride for prostate cancer prevention: Unfortunately — but far from unexpectedly —... http://bit.ly/fY0iRb

1 year ago...

Docs Shying Away From Drug That May Prevent Prostate Cancer:

health.msn.com — “Docs Shying Away From Drug That May Prevent Prostate Cancer:View full resource at health.msn.com

  • View Related
  • Share

Most Recently Shared on August 12, 2010 at 6:24 pm By:

msnhealthnews msn Health News

Docs Shying Away From Drug That May Prevent Prostate Cancer: http://bit.ly/bFKgfd

2 years ago...

FDA Panel Votes Against Drugs Said to Prevent Prostate Cancer

everydayhealth.com — “Experts were concerned about rare risk of aggressive tumors in patients using the medsView full resource at everydayhealth.com

  • View Related
  • Share

Most Recently Shared on December 3, 2010 at 12:00 am By:

Newer Drug May Help Prevent Fracture in Men With Prostate Cancer

health.yahoo.net — “WEDNESDAY, Feb. 23 (HealthDay News) -- A new drug called denosumab (Xgeva) performed somewhat better than the current standard treatment of zoledronic acid (Zometa) for preventing fractures and other bone problems in men with hormone-resistant prostate cancer, a new study suggests.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on February 25, 2011 at 2:37 pm By:

nutritionbuff Jane Anderson Healthy Eating Advisor

Newer Drug May Help Prevent Fracture in Men With Prostate Cancer http://bit.ly/giQWtQ

1 year ago...

Newer Drug May Help Prevent Fracture in Men With Prostate Cancer

health.yahoo.net — “WEDNESDAY, Feb. 23 (HealthDay News) -- A new drug called denosumab (Xgeva) performed somewhat better than the current standard treatment of zoledronic acid (Zometa) for preventing fractures and other bone problems in men with hormone-resistant prostate cancer, a new study suggests.View full resource at health.yahoo.net

  • View Related
  • Share

Most Recently Shared on February 25, 2011 at 2:22 pm By:

JennyBizRN Jennifer Ann Grisso Nurse and Active Health Library

Newer Drug May Help Prevent Fracture in Men With Prostate Cancer: WEDNESDAY, Feb. 23 (HealthDay News) -- A new ... http://bit.ly/hZjahU

1 year ago...

Preventing Prostate Cancer? - AOL Health

aolhealth.com — “Recently, the Food and Drug Administration declined the request by two large pharmaceutical companies to have their existing drugs approved for the prView full resource at aolhealth.com

  • View Related
  • Share

Most Recently Shared on January 28, 2011 at 10:18 pm By:

Aspirin May Prevent Prostate Cancer Recurrence

webmd.com — “The use of anti-clotting drugs, including aspirin, appears to lower the odds that cancer will recur in men undergoing radiation treatment for prostate cancer, researchers report.View full resource at webmd.com

  • View Related
  • Share

Most Recently Shared on November 6, 2009 at 8:35 pm By:

prostatecancer_ Prostate Cancer Support

Aspirin May Prevent Prostate Cancer Recurrence http://bit.ly/nElnh

3 years ago...

Aspirin May Prevent Prostate Cancer Recurrence

webmd.com — “The use of anti-clotting drugs, including aspirin, appears to lower the odds that cancer will recur in men undergoing radiation treatment for prostate cancer, researchers report.View full resource at webmd.com

  • View Related
  • Share

Most Recently Shared on November 6, 2009 at 8:16 pm By:

HeartsHealth Heart Health Health News

webMD: Aspirin May Prevent Prostate Cancer Recurrence http://bit.ly/4cyH02 Full http://bit.ly/4zFuGW

3 years ago...

Medical News: Little Interest in Drug to Prevent Prostate Cancer - in Oncology, Prostate Cancer from MedPage Today

medpagetoday.com — “Physicians continue to shy away from prescribing finasteride to prevent prostate cancer, despite evidence from a large clinical trial showing that the drug significantly reduced the risk, a survey shoView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on August 11, 2010 at 2:55 pm By:

medpagetoday MedPage Today Health News

Little interest in drug to prevent prostate cancer: http://bit.ly/9K8VMF

2 years ago...

The Top 3 resources shared on this topic. More resources.

Key stats and trends about this topic

Featuring the top 3 experts for this topic

Advertisement

Share via Email

Share this WisdomCard with others by embedding on your site or blog.

300x260

425x300

560x390